tm logo
A (DESIGN)
FORMALIZED

on 03 Sep 2024

Last Applicant/ Owned by

BIOTECHNOLOGIES ARAMIS INC.

2552 Boul Du Parc-TechnologiqueQuébec

QUEBEC

CA

G1P4S6

Serial Number

2347252 filed on 03rd Sep 2024

Correspondent Address

COMPLEXE JULES-DALLAIRE/TOUR OGILVY RENAULT BUREAU 1500, 2828, BOULEVARD LAURIERQUÉBEC

QUÉBEC

CA

G1V0B9

A (DESIGN)

Vienna Information


5 . 3 . 14

One leafUne feuille

5 . 3 . 11

Other leavesAutres feuilles

5 . 3 . 13

Stylized leavesFeuilles stylisées

27 . 5 . 1

Letters presenting a special form of writingLettres présentant un graphisme spécial

27 . 5 . 8

Letters linked to or containing a figurative element -- Note: Letters representing a human being or a part of the human body, an animal or a part of an animal's body, a plant, a heavenly body, a natural phenomenon or an object are classified in division 27.3.Lettres liées à un élément figuratif ou contenant un élément figuratif -- Note: Les lettres représentant un être humain ou une partie du corps humain, un animal ou une partie du corps d'un animal, un végétal, un corps céleste, un phénomène naturel ou un objet sont classées dans la division 27.3.

27 . 5 . 21

One letterUne lettre

Trademark usage description

pharmaceutical and medicinal preparations and substances, namely, recombinant proteins. manufacture of pharmaceuticals, pharmaceutical ingredients an Read More

Classification Information


Class [005]
Pharmaceutical and medicinal preparations and substances, namely, recombinant proteins.


Classification kind code

12

Class [040]
Manufacture of pharmaceuticals, pharmaceutical ingredients and human vaccines, custom manufacturing of pharmaceuticals, pharmaceutical ingredients and human vaccines.


Classification kind code

12

Class [042]
Research and development in the field of human vaccines; high-throughput vaccine engineering services; medical and scientific research services of proprietary recombinant protein platform technologies designed to lead to new human vaccines; product research and development and scientific research, all in the field of protein production using recombinant technologies through transient expression in plants; medical and scientific research services relating to infectious diseases; development of new products for others in the field of pharmaceuticals, pharmaceutical ingredients and human vaccines; medical and scientific research regarding clinical trial studies on new vaccine candidates.


Classification kind code

12

Class [044]
Medical information services, namely, providing information to physicians, healthcare professionals and patients on the topics of health issues that can be treated with vaccines, diagnostic, prophylactic and therapeutic properties of vaccines; on-line information services, namely, providing information to physicians, healthcare professionals and patients on the topics of health issues that can be treated with vaccines, diagnostic, prophylactic and therapeutic properties of vaccines.


Classification kind code

12

Mark Details


Serial Number

2347252

Mark Type

Trademark

Legal History


Action TakenStatus
Submitted for opposition 287
on 19th Sep 2024
Pre-Assessment Letter Sent
Submitted for opposition 30
on 03rd Sep 2024
Filed
Submitted for opposition 1
on 03rd Sep 2024
Created
Submitted for opposition 31
on 03rd Sep 2024
Formalized